{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:06:28Z","timestamp":1772755588838,"version":"3.50.1"},"reference-count":111,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006733","name":"Indiana University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006733","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Oncology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.omton.2025.201003","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T12:22:35Z","timestamp":1748262155000},"page":"201003","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Emerging roles of protein arginine methyltransferase in multiple myeloma"],"prefix":"10.1016","volume":"33","author":[{"given":"Sajida Fady","family":"Qaddoura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enze","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian A.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0896-8641","authenticated-orcid":false,"given":"Ngoc Tung","family":"Tran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.omton.2025.201003_bib1","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.beha.2007.08.004","article-title":"Genetic events in the pathogenesis of multiple myeloma","volume":"20","author":"Chng","year":"2007","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"10.1016\/j.omton.2025.201003_bib2","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1056\/NEJMoa1817226","article-title":"Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma","volume":"380","author":"Raje","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omton.2025.201003_bib3","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.3389\/fimmu.2018.03064","article-title":"Insights From Analysis of Human Antigen-Specific Memory B Cell Repertoires","volume":"9","author":"Shah","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2025.201003_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2017.94","article-title":"High somatic mutation and neoantigen burden are correlated with decreased progression-free survival in multiple myeloma","volume":"7","author":"Miller","year":"2017","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.omton.2025.201003_bib5","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/ajh.26590","article-title":"Multiple myeloma: 2022 update on diagnosis, risk stratification, and management","volume":"97","author":"Rajkumar","year":"2022","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.omton.2025.201003_bib6","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41408-020-00348-5","article-title":"Cytogenetic abnormalities in multiple myeloma: association with disease characteristics and treatment response","volume":"10","author":"Abdallah","year":"2020","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.omton.2025.201003_bib7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4065\/78.1.21","article-title":"Review of 1027 patients with newly diagnosed multiple myeloma","volume":"78","author":"Kyle","year":"2003","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.omton.2025.201003_bib8","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa1709974","article-title":"Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance","volume":"378","author":"Kyle","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omton.2025.201003_bib9","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pkae056","article-title":"Prevalence of monoclonal gammopathy of undetermined significance in Eswatini: a population-based study in Africa","volume":"8","author":"Cicero","year":"2024","journal-title":"JNCI Cancer Spectr."},{"key":"10.1016\/j.omton.2025.201003_bib10","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/ejh.14105","article-title":"Gaucher disease prevalence in 600 patients affected by monoclonal gammopathy of undetermined significance","volume":"111","author":"Giuffrida","year":"2023","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.omton.2025.201003_bib11","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/leu.2010.60","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management","volume":"24","author":"Kyle","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.omton.2025.201003_bib12","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1182\/blood-2014-09-568899","article-title":"Smoldering multiple myeloma","volume":"125","author":"Rajkumar","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.omton.2025.201003_bib13","doi-asserted-by":"crossref","first-page":"32","DOI":"10.4161\/cc.27353","article-title":"Protein arginine methylation of non-histone proteins and its role in diseases","volume":"13","author":"Wei","year":"2014","journal-title":"Cell Cycle"},{"key":"10.1016\/j.omton.2025.201003_bib14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.molcel.2005.04.003","article-title":"Arginine methylation an emerging regulator of protein function","volume":"18","author":"Bedford","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.omton.2025.201003_bib15","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1016\/j.molcel.2021.09.011","article-title":"Cellular pathways influenced by protein arginine methylation: Implications for cancer","volume":"81","author":"Xu","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.omton.2025.201003_bib16","article-title":"Protein Arginine Methylation: An Emerging Modification in Cancer Immunity and Immunotherapy","volume":"13","author":"Dai","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2025.201003_bib17","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/s12276-021-00613-y","article-title":"Protein arginine methyltransferases: promising targets for cancer therapy","volume":"53","author":"Hwang","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.omton.2025.201003_bib18","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/s41580-019-0155-x","article-title":"The regulation, functions and clinical relevance of arginine methylation","volume":"20","author":"Guccione","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.omton.2025.201003_bib19","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1126\/science.1060781","article-title":"Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor","volume":"293","author":"Wang","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.omton.2025.201003_bib20","doi-asserted-by":"crossref","first-page":"6608","DOI":"10.1093\/nar\/gky461","article-title":"PHD finger protein 1 (PHF1) is a novel reader for histone H4R3 symmetric dimethylation and coordinates with PRMT5-WDR77\/CRL4B complex to promote tumorigenesis","volume":"46","author":"Liu","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omton.2025.201003_bib21","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1038\/s41467-019-11696-7","article-title":"Genotoxic stress-triggered beta-catenin\/JDP2\/PRMT5 complex facilitates reestablishing glutathione homeostasis","volume":"10","author":"Cao","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omton.2025.201003_bib22","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/nature06166","article-title":"Methylation of histone H3R2 by PRMT6 and H3K4 by an MLL complex are mutually exclusive","volume":"449","author":"Guccione","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.omton.2025.201003_bib23","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1038\/s41467-018-06968-7","article-title":"PRMT2 links histone H3R8 asymmetric dimethylation to oncogenic activation and tumorigenesis of glioblastoma","volume":"9","author":"Dong","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omton.2025.201003_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2020.112152","article-title":"PRMT2 accelerates tumorigenesis of hepatocellular carcinoma by activating Bcl2 via histone H3R8 methylation","volume":"394","author":"Hu","year":"2020","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.omton.2025.201003_bib25","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1101\/gad.233239.113","article-title":"Molecular basis underlying histone H3 lysine-arginine methylation pattern readout by Spin\/Ssty repeats of Spindlin1","volume":"28","author":"Su","year":"2014","journal-title":"Genes Dev."},{"key":"10.1016\/j.omton.2025.201003_bib26","doi-asserted-by":"crossref","first-page":"13351","DOI":"10.1073\/pnas.0605692103","article-title":"Coactivator-associated arginine methyltransferase 1 (CARM1) is a positive regulator of the Cyclin E1 gene","volume":"103","author":"El Messaoudi","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omton.2025.201003_bib27","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1021\/acs.biochem.5b01071","article-title":"CARM1 Preferentially Methylates H3R17 over H3R26 through a Random Kinetic Mechanism","volume":"55","author":"Jacques","year":"2016","journal-title":"Biochemistry"},{"key":"10.1016\/j.omton.2025.201003_bib28","doi-asserted-by":"crossref","first-page":"5457","DOI":"10.1093\/emboj\/cdf548","article-title":"Control of CBP co-activating activity by arginine methylation","volume":"21","author":"Chevillard-Briet","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.omton.2025.201003_bib29","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1126\/science.1065961","article-title":"A transcriptional switch mediated by cofactor methylation","volume":"294","author":"Xu","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.omton.2025.201003_bib30","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S1097-2765(03)00101-1","article-title":"Methylation of SPT5 regulates its interaction with RNA polymerase II and transcriptional elongation properties","volume":"11","author":"Kwak","year":"2003","journal-title":"Mol. Cell"},{"key":"10.1016\/j.omton.2025.201003_bib31","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1091\/mbc.e02-08-0484","article-title":"Sam68 RNA binding protein is an in vivo substrate for protein arginine N-methyltransferase 1","volume":"14","author":"Cote","year":"2003","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.omton.2025.201003_bib32","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1006\/excr.2000.4827","article-title":"The RGG domain in hnRNP A2 affects subcellular localization","volume":"256","author":"Nichols","year":"2000","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.omton.2025.201003_bib33","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/hmg\/ddr448","article-title":"Arginine methylation by PRMT1 regulates nuclear-cytoplasmic localization and toxicity of FUS\/TLS harbouring ALS-linked mutations","volume":"21","author":"Tradewell","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omton.2025.201003_bib34","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jmb.2016.12.011","article-title":"Methylarginines within the RGG-Motif Region of hnRNP A1 Affect Its IRES Trans-Acting Factor Activity and Are Required for hnRNP A1 Stress Granule Localization and Formation","volume":"429","author":"Wall","year":"2017","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.omton.2025.201003_bib35","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/S0960-9822(01)00592-9","article-title":"Methylation of Sm proteins by a complex containing PRMT5 and the putative U snRNP assembly factor pICln","volume":"11","author":"Meister","year":"2001","journal-title":"Curr. Biol."},{"key":"10.1016\/j.omton.2025.201003_bib36","doi-asserted-by":"crossref","first-page":"5853","DOI":"10.1093\/emboj\/cdf585","article-title":"Assisted RNP assembly: SMN and PRMT5 complexes cooperate in the formation of spliceosomal UsnRNPs","volume":"21","author":"Meister","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.omton.2025.201003_bib37","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/s41594-019-0313-z","article-title":"PRMT5 methylome profiling uncovers a direct link to splicing regulation in acute myeloid leukemia","volume":"26","author":"Radzisheuskaya","year":"2019","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.omton.2025.201003_bib38","doi-asserted-by":"crossref","first-page":"16723","DOI":"10.1074\/jbc.M115.659433","article-title":"Unique Features of Human Protein Arginine Methyltransferase 9 (PRMT9) and Its Substrate RNA Splicing Factor SF3B2","volume":"290","author":"Hadjikyriacou","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omton.2025.201003_bib39","doi-asserted-by":"crossref","first-page":"6428","DOI":"10.1038\/ncomms7428","article-title":"PRMT9 is a type II methyltransferase that methylates the splicing factor SAP145","volume":"6","author":"Yang","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omton.2025.201003_bib40","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.06234","article-title":"Aven recognition of RNA G-quadruplexes regulates translation of the mixed lineage leukemia protooncogenes","volume":"4","author":"Thandapani","year":"2015","journal-title":"eLife"},{"key":"10.1016\/j.omton.2025.201003_bib41","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1038\/sj.emboj.7600265","article-title":"PRMT3 is a ribosomal protein methyltransferase that affects the cellular levels of ribosomal subunits","volume":"23","author":"Bachand","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.omton.2025.201003_bib42","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1074\/jbc.RA118.004928","article-title":"The 40S ribosomal protein uS5 (RPS2) assembles into an extraribosomal complex with human ZNF277 that competes with the PRMT3-uS5 interaction","volume":"294","author":"Dionne","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omton.2025.201003_bib43","doi-asserted-by":"crossref","first-page":"16917","DOI":"10.1074\/jbc.M609778200","article-title":"Ribosomal protein rpS2 is hypomethylated in PRMT3-deficient mice","volume":"282","author":"Swiercz","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omton.2025.201003_bib44","first-page":"4359","article-title":"PRMT5 regulates IRES-dependent translation via methylation of hnRNP A1","volume":"45","author":"Gao","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omton.2025.201003_bib45","doi-asserted-by":"crossref","first-page":"12695","DOI":"10.1074\/jbc.M110.103911","article-title":"Methylation of ribosomal protein S10 by protein-arginine methyltransferase 5 regulates ribosome biogenesis","volume":"285","author":"Ren","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omton.2025.201003_bib46","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.molcel.2016.11.003","article-title":"Arginine Methylation: The Coming of Age","volume":"65","author":"Blanc","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.omton.2025.201003_bib47","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41580-019-0166-7","article-title":"Author Correction: The regulation, functions and clinical relevance of arginine methylation","volume":"20","author":"Guccione","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.omton.2025.201003_bib48","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1139\/bcb-2023-0212","article-title":"Protein arginine methyltransferase 1, a major regulator of biological processes","volume":"102","author":"Sudhakar","year":"2024","journal-title":"Biochem. Cell. Biol."},{"key":"10.1016\/j.omton.2025.201003_bib49","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/leu.2017.334","article-title":"Protein arginine methyltransferase 5 has prognostic relevance and is a druggable target in multiple myeloma","volume":"32","author":"Gulla","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.omton.2025.201003_bib50","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41419-023-06036-z","article-title":"PRMT1 methylation of WTAP promotes multiple myeloma tumorigenesis by activating oxidative phosphorylation via m6A modification of NDUFS6","volume":"14","author":"Jia","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.omton.2025.201003_bib51","article-title":"Protein arginine methyltransferase 1 is a therapeutic vulnerability in multiple myeloma","volume":"14","author":"Nguyen","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2025.201003_bib52","doi-asserted-by":"crossref","first-page":"7723","DOI":"10.1074\/jbc.275.11.7723","article-title":"PRMT1 is the predominant type I protein arginine methyltransferase in mammalian cells","volume":"275","author":"Tang","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omton.2025.201003_bib53","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nrc3409","article-title":"Protein arginine methyltransferases and cancer","volume":"13","author":"Yang","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.omton.2025.201003_bib54","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1007\/s00018-019-03145-x","article-title":"Protein arginine methyltransferases: insights into the enzyme structure and mechanism at the atomic level","volume":"76","author":"Tewary","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.omton.2025.201003_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/life11111147","article-title":"Structure, Activity, and Function of PRMT1","volume":"11","author":"Thiebaut","year":"2021","journal-title":"Life"},{"key":"10.1016\/j.omton.2025.201003_bib56","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1038\/s41467-023-38443-3","article-title":"PRMT1 mediated methylation of cGAS suppresses anti-tumor immunity","volume":"14","author":"Liu","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omton.2025.201003_bib57","doi-asserted-by":"crossref","first-page":"440","DOI":"10.4049\/jimmunol.1701654","article-title":"PRMT1 Plays a Critical Role in Th17 Differentiation by Regulating Reciprocal Recruitment of STAT3 and STAT5","volume":"201","author":"Sen","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.omton.2025.201003_bib58","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1016\/j.ymthe.2023.09.011","article-title":"Targeting PRMT1 prevents acute and chronic graft-versus-host disease","volume":"31","author":"Zhao","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omton.2025.201003_bib59","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1158\/2326-6066.CIR-21-0614","article-title":"Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell-Mediated Antitumor Immune Responses","volume":"10","author":"Fedoriw","year":"2022","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.omton.2025.201003_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.113831","article-title":"PRMT1 acts as a suppressor of MHC-I and anti-tumor immunity","volume":"43","author":"Djajawi","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.omton.2025.201003_bib61","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1158\/0008-5472.CAN-23-1082","article-title":"PRMT1 Inhibition Activates the Interferon Pathway to Potentiate Antitumor Immunity and Enhance Checkpoint Blockade Efficacy in Melanoma","volume":"84","author":"Tao","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.omton.2025.201003_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2023.100912","article-title":"PRMT1 methylates METTL14 to modulate its oncogenic function","volume":"42","author":"Wang","year":"2023","journal-title":"Neoplasia"},{"key":"10.1016\/j.omton.2025.201003_bib63","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1038\/s41467-021-24035-6","article-title":"Arginine methylation of METTL14 promotes RNA N(6)-methyladenosine modification and endoderm differentiation of mouse embryonic stem cells","volume":"12","author":"Liu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omton.2025.201003_bib64","doi-asserted-by":"crossref","first-page":"5393","DOI":"10.1038\/s41388-021-01939-7","article-title":"IDH2 contributes to tumorigenesis and poor prognosis by regulating m6A RNA methylation in multiple myeloma","volume":"40","author":"Song","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.omton.2025.201003_bib65","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/s41388-021-02095-8","article-title":"RNA demethylase ALKBH5 promotes tumorigenesis in multiple myeloma via TRAF1-mediated activation of NF-kappaB and MAPK signaling pathways","volume":"41","author":"Qu","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.omton.2025.201003_bib66","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1158\/0008-5472.CAN-07-1983","article-title":"CARM1 regulates estrogen-stimulated breast cancer growth through up-regulation of E2F1","volume":"68","author":"Frietze","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.omton.2025.201003_bib67","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1128\/MCB.00815-06","article-title":"The activity and stability of the transcriptional coactivator p\/CIP\/SRC-3 are regulated by CARM1-dependent methylation","volume":"27","author":"Naeem","year":"2007","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.omton.2025.201003_bib68","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15571","article-title":"Global mapping of CARM1 substrates defines enzyme specificity and substrate recognition","volume":"8","author":"Shishkova","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omton.2025.201003_bib69","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ccr.2013.12.007","article-title":"CARM1 methylates chromatin remodeling factor BAF155 to enhance tumor progression and metastasis","volume":"25","author":"Wang","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omton.2025.201003_bib70","article-title":"A role for CARM1-mediated histone H3 arginine methylation in protecting histone acetylation by releasing corepressors from chromatin","volume":"7","author":"Wu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.omton.2025.201003_bib71","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/sj.embor.7401151","article-title":"CARM1 promotes adipocyte differentiation by coactivating PPARgamma","volume":"9","author":"Yadav","year":"2008","journal-title":"EMBO Rep."},{"key":"10.1016\/j.omton.2025.201003_bib72","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1746-1596-8-129","article-title":"Overexpression of CARM1 in breast cancer is correlated with poorly characterized clinicopathologic parameters and molecular subtypes","volume":"8","author":"Cheng","year":"2013","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.omton.2025.201003_bib73","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/cncr.20327","article-title":"Aberrant expression of CARM1, a transcriptional coactivator of androgen receptor, in the development of prostate carcinoma and androgen-independent status","volume":"101","author":"Hong","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.omton.2025.201003_bib74","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3390\/pathogens1010052","article-title":"Arginine Methyltransferases Are Regulated by Epstein-Barr Virus in B Cells and Are Differentially Expressed in Hodgkin's Lymphoma","volume":"1","author":"Leonard","year":"2012","journal-title":"Pathogens"},{"key":"10.1016\/j.omton.2025.201003_bib75","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.3892\/or.2013.2651","article-title":"Elevated expression of coactivator-associated arginine methyltransferase 1 is associated with early hepatocarcinogenesis","volume":"30","author":"Osada","year":"2013","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.omton.2025.201003_bib76","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.celrep.2013.11.025","article-title":"PRMT4 blocks myeloid differentiation by assembling a methyl-RUNX1-dependent repressor complex","volume":"5","author":"Vu","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.omton.2025.201003_bib77","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1002\/pros.20438","article-title":"Involvement of arginine methyltransferase CARM1 in androgen receptor function and prostate cancer cell viability","volume":"66","author":"Majumder","year":"2006","journal-title":"Prostate"},{"key":"10.1016\/j.omton.2025.201003_bib78","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.2147\/OTT.S125067","article-title":"miR-195 enhances the radiosensitivity of colorectal cancer cells by suppressing CARM1","volume":"10","author":"Zheng","year":"2017","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.omton.2025.201003_bib79","doi-asserted-by":"crossref","first-page":"7457","DOI":"10.1007\/s11033-023-08645-5","article-title":"Inhibition of CARM1 suppresses proliferation of multiple myeloma cells through activation of p53 signaling pathway","volume":"50","author":"Yang","year":"2023","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.omton.2025.201003_bib80","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-18446-z","article-title":"Identification of a CARM1 Inhibitor with Potent In Vitro and In Vivo Activity in Preclinical Models of Multiple Myeloma","volume":"7","author":"Drew","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omton.2025.201003_bib81","doi-asserted-by":"crossref","first-page":"18480","DOI":"10.18632\/oncotarget.24883","article-title":"TP-064, a potent and selective small molecule inhibitor of PRMT4 for multiple myeloma","volume":"9","author":"Nakayama","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.omton.2025.201003_bib82","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aat8388","article-title":"Proteomics profiling of arginine methylation defines PRMT5 substrate specificity","volume":"12","author":"Musiani","year":"2019","journal-title":"Sci. Signal."},{"key":"10.1016\/j.omton.2025.201003_bib83","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/nsmb.2209","article-title":"Symmetric dimethylation of H3R2 is a newly identified histone mark that supports euchromatin maintenance","volume":"19","author":"Migliori","year":"2012","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.omton.2025.201003_bib84","doi-asserted-by":"crossref","first-page":"9630","DOI":"10.1128\/MCB.24.21.9630-9645.2004","article-title":"Human SWI\/SNF-associated PRMT5 methylates histone H3 arginine 8 and negatively regulates expression of ST7 and NM23 tumor suppressor genes","volume":"24","author":"Pal","year":"2004","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.omton.2025.201003_bib85","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1016\/j.celrep.2018.08.002","article-title":"PRMT5 Regulates DNA Repair by Controlling the Alternative Splicing of Histone-Modifying Enzymes","volume":"24","author":"Hamard","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.omton.2025.201003_bib86","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jbior.2014.09.003","article-title":"Protein arginine methyltransferases (PRMTs): role in chromatin organization","volume":"57","author":"Jahan","year":"2015","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.omton.2025.201003_bib87","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202002602","article-title":"Protein Arginine Methyltransferase PRMT5 Regulates Fatty Acid Metabolism and Lipid Droplet Biogenesis in White Adipose Tissues","volume":"7","author":"Jia","year":"2020","journal-title":"Adv. Sci."},{"key":"10.1016\/j.omton.2025.201003_bib88","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1038\/s41467-021-21963-1","article-title":"Profiling PRMT methylome reveals roles of hnRNPA1 arginine methylation in RNA splicing and cell growth","volume":"12","author":"Li","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omton.2025.201003_bib89","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41467-018-07884-6","article-title":"PRMT5 is essential for B cell development and germinal center dynamics","volume":"10","author":"Litzler","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omton.2025.201003_bib90","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1172\/JCI81749","article-title":"Arginine methyltransferase PRMT5 is essential for sustaining normal adult hematopoiesis","volume":"125","author":"Liu","year":"2015","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omton.2025.201003_bib91","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1007\/s00018-019-03140-2","article-title":"Cellular consequences of arginine methylation","volume":"76","author":"Lorton","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.omton.2025.201003_bib92","doi-asserted-by":"crossref","first-page":"8407","DOI":"10.1021\/acs.jmedchem.3c00250","article-title":"Targeting Arginine Methyltransferase PRMT5 for Cancer Therapy: Updated Progress and Novel Strategies","volume":"66","author":"Zheng","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.omton.2025.201003_bib93","doi-asserted-by":"crossref","DOI":"10.3390\/genes14030678","article-title":"The Role of PRMT5 in Immuno-Oncology","volume":"14","author":"Abe","year":"2023","journal-title":"Genes"},{"key":"10.1016\/j.omton.2025.201003_bib94","doi-asserted-by":"crossref","first-page":"199","DOI":"10.15698\/cst2020.08.228","article-title":"PRMT5 function and targeting in cancer","volume":"4","author":"Kim","year":"2020","journal-title":"Cell Stress"},{"key":"10.1016\/j.omton.2025.201003_bib95","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14215443","article-title":"Protein Arginine Methyltransferases as Therapeutic Targets in Hematological Malignancies","volume":"14","author":"Sauter","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.omton.2025.201003_bib96","doi-asserted-by":"crossref","first-page":"36705","DOI":"10.18632\/oncotarget.26404","article-title":"Protein arginine methyltransferase 5 (PRMT5) dysregulation in cancer","volume":"9","author":"Shailesh","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.omton.2025.201003_bib97","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41573-021-00159-8","article-title":"Protein arginine methylation: from enigmatic functions to therapeutic targeting","volume":"20","author":"Wu","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omton.2025.201003_bib98","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.gendis.2019.06.002","article-title":"PRMT5 in gene regulation and hematologic malignancies","volume":"6","author":"Zhu","year":"2019","journal-title":"Genes Dis."},{"key":"10.1016\/j.omton.2025.201003_bib99","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41392-021-00507-5","article-title":"Pyroptosis: mechanisms and diseases","volume":"6","author":"Yu","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.omton.2025.201003_bib100","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/s41419-021-04373-5","article-title":"Correction: PRMT5 regulates cell pyroptosis by silencing CASP1 in multiple myeloma","volume":"12","author":"Xia","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.omton.2025.201003_bib101","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.879057","article-title":"Inhibition of the Protein Arginine Methyltransferase PRMT5 in High-Risk Multiple Myeloma as a Novel Treatment Approach","volume":"10","author":"Vlummens","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.omton.2025.201003_bib102","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1080\/13543776.2022.2163162","article-title":"An updated patent review of protein arginine N-methyltransferase inhibitors (2019-2022)","volume":"32","author":"Dong","year":"2022","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.omton.2025.201003_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.101016","article-title":"Promising role of protein arginine methyltransferases in overcoming anti-cancer drug resistance","volume":"72","author":"Zhu","year":"2024","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.omton.2025.201003_bib104","doi-asserted-by":"crossref","DOI":"10.1177\/20406207241275376","article-title":"Phase I\/II study of the clinical activity and safety of GSK3326595 in patients with myeloid neoplasms","volume":"15","author":"Watts","year":"2024","journal-title":"Ther. Adv. Hematol."},{"key":"10.1016\/j.omton.2025.201003_bib105","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1158\/1078-0432.CCR-23-0092","article-title":"Phase 1 Study of JNJ-64619178, a Protein Arginine Methyltransferase 5 Inhibitor, in Advanced Solid Tumors","volume":"29","author":"Vieito","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omton.2025.201003_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2023.106634","article-title":"PRT543, a protein arginine methyltransferase 5 inhibitor, in patients with advanced adenoid cystic carcinoma: An open-label, phase I dose-expansion study","volume":"149","author":"Ferrarotto","year":"2024","journal-title":"Oral Oncol."},{"key":"10.1016\/j.omton.2025.201003_bib107","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ccell.2019.05.014","article-title":"Anti-tumor Activity of the Type I PRMT Inhibitor, GSK3368715, Synergizes with PRMT5 Inhibition through MTAP Loss","volume":"36","author":"Fedoriw","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omton.2025.201003_bib108","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41416-023-02276-0","article-title":"Phase 1 study of GSK3368715, a type I PRMT inhibitor, in patients with advanced solid tumors","volume":"129","author":"El-Khoueiry","year":"2023","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.omton.2025.201003_bib109","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.1021\/acs.jmedchem.0c01895","article-title":"Discovery of AG-270, a First-in-Class Oral MAT2A Inhibitor for the Treatment of Tumors with Homozygous MTAP Deletion","volume":"64","author":"Konteatis","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.omton.2025.201003_bib110","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.annonc.2024.08.2339","article-title":"First-in-human study of AMG 193, an MTA-cooperative PRMT5 inhibitor, in patients with MTAP-deleted solid tumors: results from phase I dose exploration","volume":"35","author":"Rodon","year":"2024","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.omton.2025.201003_bib111","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ccell.2019.07.003","article-title":"Therapeutic Targeting of RNA Splicing Catalysis through Inhibition of Protein Arginine Methylation","volume":"36","author":"Fong","year":"2019","journal-title":"Cancer Cell"}],"container-title":["Molecular Therapy Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329925000724?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329925000724?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T03:02:23Z","timestamp":1762657343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950329925000724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":111,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2950329925000724"],"URL":"https:\/\/doi.org\/10.1016\/j.omton.2025.201003","relation":{},"ISSN":["2950-3299"],"issn-type":[{"value":"2950-3299","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging roles of protein arginine methyltransferase in multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omton.2025.201003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201003"}}